HEALTHCARE SOLUTIONS MANAGEMENT GROUP, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Change in Officers and Director Resignation

On December 27, 2022, Justin Smith was removed as a member of the Board of
Directors of Healthcare Solutions Management Group, Inc. (the “Company”)
effective immediately. Mr. Smith was previously appointed on April 15, 2021 as
the Executive Chairman and member of the Board of Directors of the Company. Mr.
Smith’s removal was as a result of the Company’s desire to reduce costs and
increase internal efficiency and was not the result of any disagreement with the
Company on any matter relating to the Company’s operations, policies or
practices.

On February 9, 2023. Mr. Smith was let go as the Company’s Interim Chief
Executive Officer and Interim Chief Financial Officer. Mr. Smith was previously
appointed as the Company’s Interim Chief Executive Officer and Interim Chief
Financial Officer On April 15, 2021. Mr. Smith was let go as a result of the
Company’s desire to reduce costs and increase internal efficiency and not as a
result of any disagreement with the Company on any matter relating to the
Company’s operations, policies or practices.

On February 9, 2023, Jonathan Loutzenhiser the Company’s Executive Vice
President and a member of the Company’s Board of Directors, agreed to act as the
Company’s Interim Chief Executive Officer and Interim Chief Financial Officer. Jonathan Loutzenhiser, age 36, was previously appointed as Executive Vice
President of the Company and a member of the Board of Directors of the Company
on April 15, 2021. From 2013 to 2014 Mr. Loutzenhiser worked as a sports agent
at Recruiting. From 2015 to 2016, Mr. Loutzenhiser served as the Chief Executive
Officer at Mediplex. From 2016 to 2017, Mr. Loutzenhiser was the President of
IneedMD. He serves as the Executive Vice President of Healthcare Solutions
Holdings, Inc, the Company’s wholly owned subsidiary (“HSH”) and a member of the
Board of Directors of HSH since he was appointed to such positions on October 1,
2017 and holds this position to date. Mr. Loutzenhiser graduated from Grace
University with a degree in business management in 2012.

Separation and Release Agreement

On February 9, 2023, the Company entered into a Separation, Release of Claims
and Non-Disclosure Agreement (the “Agreement’) with Justin Smith. Pursuant to
the Agreement, it was agreed that the investment of $93,933,345.48 (the “Landes
Investment“) which was made in HSH, by Landes Capital Management LLC and Landes
and Compagnie Trust Prive KB (collectively referred to herein as “Landes”) which Mr. Smith also serves as the Managing Director of, will be returned to Landes in
exchange for Landes returning to the Company the 1,000,000 shares of the
Company’s common stock that were issued to Landes in connection to the Landes
Investment.

The Agreement also contains a general release by Mr. Smith of the Company as
well as its parents, subsidiaries, corporate affiliates, employees, officers,
directors, owners, shareholders and agents, individually and in their official
capacities. The Agreement also contains a general release by the Company of Mr.
Smith. Additionally, the Agreement also provides that the Company agrees to
indemnify Mr. Smith in connection with any litigation arising out of any action,
suit or proceeding by reason of his service as an executive with the Company.
Further, pursuant to the Agreement, Mr. Smith agreed to keep confidential, the
“Confidential Information” of the Company as such term is defined in the
Agreement.

Additionally, pursuant to the Agreement, in the event of a material breach by Mr. Smith of any of the provisions of the Agreement, Mr. Smith agreed that the
Company will be entitled to seek, in addition to other available remedies, an
award for liquidated damages in an amount equal to $100,000.00 for each material
breach. Pursuant to the Agreement, the Company agreed that in the event of a
material breach by the Company of any of the provisions of the Agreement, Mr.
Smith will be entitled to seek, in addition to other available remedies, an
award for liquidated damages in an amount equal to $100,000.00 for each material
breach.

The foregoing description of the Agreement does not purport to be complete and
is qualified in its entirety by reference to the Agreement, which is filed as
Exhibit 10.1 hereto and is incorporated by reference herein.

Item 9.01 – Financial Statement and Exhibits.

(d) Exhibits

The following exhibits are filed with this report:

Exhibit No.   Description

  10.1*         Separation Agreement dated February 9, 2023.
104*          Cover Page Interactive Data File (formatted as Inline XBRL)


_____________

* Filed herewith.





2

© Edgar Online, source Glimpses